Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-29 Purchase | 2024-11-05 12:42 pm | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 13,252,112 | $0 | $0 | 29,823,881 (Direct) | View |
| 2023-09-11 Purchase | 2023-09-11 8:24 pm | Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner | 2,053,789 | $0.5112 | $1,049,897 | 12,502,868 (Indirect Direct) | View |
| 2023-07-31 Purchase | 2023-08-25 7:33 pm | Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner | 880,195 | $0.5113 | $450,044 | 7,515,093 (Indirect Direct) | View |
| 2023-01-04 Purchase | 2023-01-06 4:45 pm | Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner | 743,243 | $1.23 | $914,189 | 5,177,653 (Indirect Direct) | View |
| 2022-12-02 Purchase | 2022-12-06 9:02 pm | Eterna Therapeutics Inc. | ERNA | Cherington Charles Director 10% Owner | 261,756 | $3.28 | $858,560 | 1,079,977 (Direct) | View |
| 2022-10-20 Purchase | 2022-10-24 4:03 pm | Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner | 15,007 | $1.5779 | $23,680 | 2,204,681 (Indirect Direct) | View |
| 2022-10-14 Purchase | 2022-10-18 4:04 pm | Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner | 19,519 | $1.648 | $32,167 | 2,189,674 (Indirect Direct) | View |
| 2022-10-13 Purchase | 2022-10-14 4:03 pm | Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner | 10,481 | $1.6589 | $17,387 | 2,170,155 (Indirect Direct) | View |
| 2022-09-29 Purchase | 2022-09-30 4:04 pm | Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner | 17,900 | $1.8702 | $33,477 | 2,159,674 (Indirect Direct) | View |
| 2022-09-27 Purchase | 2022-09-29 4:02 pm | Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner | 12,000 | $1.6851 | $20,221 | 2,141,774 (Indirect Direct) | View |
| 2021-06-16 Sale | 2021-06-21 6:00 pm | Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director 10% Owner | 400,000 | $15.74 | $6,296,568 | 5,894,101 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-29 Conversion | 2024-11-05 12:42 pm | N/A 2025-09-24 | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 1,368,626 | $0 | 29,823,881 (Direct) | View |
| 2024-10-29 Conversion | 2024-11-05 12:42 pm | N/A N/A | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 2,819,546 | $0.5 | 29,823,881 (Direct) | View |
| 2023-12-14 Expired | 2023-12-20 10:05 am | 2023-07-14 2028-07-14 | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 2,831,204 | $0 | 8,957,180 (Direct) | View |
Ownership | 2022-09-14 8:04 pm | N/A N/A | Comera Life Sciences Holdings Inc. | CMRA | Cherington Charles 10% Owner | 0 | $0 | 2,129,774 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-03 8:01 pm | N/A 2032-08-01 | Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director | 380,900 | $0 | 380,900 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 9:00 pm | N/A 2031-12-07 | Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director | 67,000 | $0 | 5,961,285 (Direct) | View |
| 2021-06-01 Other | 2021-12-10 9:00 pm | N/A N/A | Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director | 92 | $0 | 5,961,285 (Direct) | View |
Ownership | 2021-04-19 7:34 pm | N/A N/A | Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director 10% Owner | 0 | $0 | 6,313,297 (Direct) | View |